Biomaterials for enhancing anti-cancer immunity.
Curr Opin Biotechnol. 2016 Feb 17;40:1-8
Authors: Koshy ST, Mooney DJ
Abstract
Cancer immunotherapy is becoming a standard approach to treat many cancers. However, shortcomings of current methods limit therapeutic benefit in many patients. Rationally designed biomaterial strategies to deliver immune modulatory drugs can potentially show improved safety profiles, while providing multifunctional and spatiotemporally controlled signals to immune cells to improve their anti-cancer activity. This brief review describes biomaterials-based strategies that enhance immune cell function at various tissue sites to improve anti-cancer immunity. Continued collaboration between bioengineers, immunologists, industry, and clinicians is required for biomaterial-based immunotherapy strategies to continue moving to the clinic.
PMID: 26896596 [PubMed - as supplied by publisher]
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/24jDLpO
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου